• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国葡萄膜黑色素瘤的检测和治疗时机:2384 例患者的评估。

Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients.

机构信息

Bristol Eye Hospital, Lower Maudlin Street, Bristol BS1 2LX, UK.

出版信息

Ophthalmology. 2012 Aug;119(8):1582-9. doi: 10.1016/j.ophtha.2012.01.048. Epub 2012 Apr 11.

DOI:10.1016/j.ophtha.2012.01.048
PMID:22503229
Abstract

PURPOSE

To determine the mode of detection of uveal melanoma and time to treatment in the United Kingdom.

DESIGN

Prospective cohort study.

PARTICIPANTS

A total of 2384 patients diagnosed with uveal melanoma at the Liverpool Ocular Oncology Center between 1996 and early 2011.

METHODS

A questionnaire was completed with every new patient, and the results were correlated with clinical features and treatment.

MAIN OUTCOME MEASURES

Tumor detection, practitioner initiating referral, referral pathway, time to treatment, baseline clinical features, and primary ocular treatment.

RESULTS

The referral process was initiated by an optometrist, family doctor, or ophthalmologist in 68.0%, 18.2%, and 13.8% of patients, respectively. On referral, 30.2% of patients were asymptomatic. Twenty-three percent of patients reported that their tumor was initially missed; these tended to have a more advanced tumor when they reached our center. The time from referral to treatment had a median of 49 days, exceeding 6 months in 19.8% of patients. This delay was longer in patients who reported that their tumor was missed (median, 92 vs. 40 days; Mann-Whitney, P<0.001). Ophthalmologists delayed the referral process by more than 6 months in 10.9% of patients. Primary enucleation was performed in 33.3% of patients and was more likely in those who reported that their tumor was missed (44.8% vs. 29.8%; chi-square, P<0.001).

CONCLUSIONS

Many patients with uveal melanoma experience long delays in treatment because their tumor was missed or misdiagnosed. Such patients tend to have a more advanced tumor by the time they reach an oncology center and are more likely to require enucleation.

摘要

目的

确定英国葡萄膜黑色素瘤的检测方式和治疗时间。

设计

前瞻性队列研究。

参与者

共有 2384 例在 1996 年至 2011 年初期间在利物浦眼部肿瘤中心被诊断为葡萄膜黑色素瘤的患者。

方法

为每位新患者填写一份问卷,并将结果与临床特征和治疗相关联。

主要观察指标

肿瘤检测、医生发起转诊、转诊途径、治疗时间、基线临床特征和主要眼部治疗。

结果

转诊过程分别由验光师、家庭医生和眼科医生发起,占 68.0%、18.2%和 13.8%的患者。转诊时,30.2%的患者无症状。23%的患者报告其肿瘤最初被漏诊;这些患者到达我们中心时肿瘤往往更晚期。从转诊到治疗的中位时间为 49 天,超过 6 个月的患者占 19.8%。报告肿瘤漏诊的患者的延迟时间更长(中位数 92 天 vs. 40 天;Mann-Whitney,P<0.001)。10.9%的患者的眼科医生延迟转诊过程超过 6 个月。33.3%的患者进行了初次眼球摘除术,报告肿瘤漏诊的患者更可能进行该手术(44.8% vs. 29.8%;卡方检验,P<0.001)。

结论

许多葡萄膜黑色素瘤患者的治疗存在长时间的延迟,因为他们的肿瘤被漏诊或误诊。这些患者到达肿瘤中心时往往肿瘤更晚期,更可能需要眼球摘除术。

相似文献

1
Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients.英国葡萄膜黑色素瘤的检测和治疗时机:2384 例患者的评估。
Ophthalmology. 2012 Aug;119(8):1582-9. doi: 10.1016/j.ophtha.2012.01.048. Epub 2012 Apr 11.
2
Time to treatment of uveal melanoma in the United Kingdom.
Eye (Lond). 2001 Apr;15(Pt 2):155-8. doi: 10.1038/eye.2001.51.
3
Delays in the diagnosis of uveal melanoma and effect on treatment.葡萄膜黑色素瘤的诊断延误及其对治疗的影响。
Eye (Lond). 1998;12 ( Pt 5):781-2. doi: 10.1038/eye.1998.202.
4
Preventable delays in the treatment of intraocular melanoma in the UK.
Eye (Lond). 1996;10 ( Pt 1):127-9. doi: 10.1038/eye.1996.22.
5
Diagnosis and treatment of uveal melanoma.葡萄膜黑色素瘤的诊断与治疗
Semin Oncol. 1996 Dec;23(6):763-7.
6
Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.眼皮肤黑素细胞增多症与葡萄膜黑色素瘤转移率的关系:7872 例连续眼分析。
JAMA Ophthalmol. 2013 Aug;131(8):993-1003. doi: 10.1001/jamaophthalmol.2013.129.
7
Nondiagnosed uveal melanomas.未确诊的葡萄膜黑色素瘤。
Ophthalmology. 2004 Mar;111(3):554-7. doi: 10.1016/j.ophtha.2003.07.002.
8
Early subclinical macular edema in eyes with uveal melanoma: association with future cystoid macular edema.葡萄膜黑色素瘤眼的早期亚临床黄斑水肿:与未来囊样黄斑水肿的关系。
Ophthalmology. 2015 May;122(5):1023-9. doi: 10.1016/j.ophtha.2014.12.034. Epub 2015 Feb 14.
9
Cytogenetics of uveal melanoma: a 7-year clinical experience.葡萄膜黑色素瘤的细胞遗传学:7年临床经验
Ophthalmology. 2007 Oct;114(10):1925-31. doi: 10.1016/j.ophtha.2007.06.012. Epub 2007 Aug 27.
10
Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.以色列过去二十年的葡萄膜黑色素瘤:特征、治疗与预后
Isr Med Assoc J. 2009 May;11(5):280-5.

引用本文的文献

1
Allele-specific depletion of via siRNA or an rAAV2-shRNA vector induces selective toxicity in uveal melanoma cells.通过小干扰RNA(siRNA)或重组腺相关病毒2型短发夹RNA(rAAV2-shRNA)载体进行等位基因特异性缺失,可在葡萄膜黑色素瘤细胞中诱导选择性毒性。
Mol Ther Oncol. 2025 Jul 17;33(3):201020. doi: 10.1016/j.omton.2025.201020. eCollection 2025 Sep 18.
2
Meta-analysis of uveal melanoma genome-wide association studies identifies novel risk loci and population effect size heterogeneity.葡萄膜黑色素瘤全基因组关联研究的荟萃分析确定了新的风险位点和人群效应大小异质性。
HGG Adv. 2025 Jun 9;6(3):100465. doi: 10.1016/j.xhgg.2025.100465.
3
Current Treatment of Uveal Melanoma.
葡萄膜黑色素瘤的当前治疗方法
Cancers (Basel). 2025 Apr 23;17(9):1403. doi: 10.3390/cancers17091403.
4
The Small Choroidal Melanoma: Diagnosis, Treatment Outcomes, and Unending Controversy.小脉络膜黑色素瘤:诊断、治疗结果及无尽的争议
Semin Ophthalmol. 2025 Mar 21:1-10. doi: 10.1080/08820538.2025.2480188.
5
An Approach to Predict Intraocular Diseases by Machine Learning Based on Vitreous Humor Immune Mediator Profile.一种基于玻璃体液免疫介质谱通过机器学习预测眼内疾病的方法。
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):38. doi: 10.1167/iovs.66.3.38.
6
Artificial intelligence in the diagnosis of uveal melanoma: advances and applications.人工智能在葡萄膜黑色素瘤诊断中的进展与应用
Exp Biol Med (Maywood). 2025 Feb 19;250:10444. doi: 10.3389/ebm.2025.10444. eCollection 2025.
7
Co-isolation of human donor eye cells and development of oncogene-mutated melanocytes to study uveal melanoma.共分离人供体眼细胞并培养致癌基因突变的黑色素细胞以研究葡萄膜黑色素瘤。
BMC Biol. 2025 Jan 21;23(1):16. doi: 10.1186/s12915-025-02118-w.
8
Differentiating Choroidal Melanomas and Nevi Using a Self-Supervised Deep Learning Model Applied to Clinical Fundoscopy Images.使用应用于临床眼底镜图像的自监督深度学习模型鉴别脉络膜黑色素瘤和痣。
Ophthalmol Sci. 2024 Nov 8;5(2):100647. doi: 10.1016/j.xops.2024.100647. eCollection 2025 Mar-Apr.
9
Performance of the MOLES and TFSOM-DIM scores in classifying choroidal nevi and melanoma.MOLES 和 TFSOM-DIM 评分在脉络膜痣和黑色素瘤分类中的表现。
Sci Rep. 2024 Nov 18;14(1):28534. doi: 10.1038/s41598-024-78692-w.
10
Assessment of ferroptosis as a promising candidate for metastatic uveal melanoma treatment and prognostication.评估铁死亡作为转移性葡萄膜黑色素瘤治疗和预后的一个有前景的候选因素。
Front Pharmacol. 2024 Oct 1;15:1466896. doi: 10.3389/fphar.2024.1466896. eCollection 2024.